banner-AVANCE_IVDr_onebay.jpg
Surgeons with two new AVANCE 600 MHz NMR systems at the Imperial/St. Mary’s Clinical Phenome Center (London, UK)
Surgeons with two new AVANCE 600 MHz NMR systems at the Imperial/St. Mary’s Clinical Phenome Center (London, UK)

“The latest generation of Bruker NMR instruments gives us staggering day to day and long term reproducibility and reliability of spectral acquisition, coupled with the ability to do automated digital quantification of multiple metabolites.  Thus, uniquely, the NMR technology platform can be used in simultaneous exploratory and targeted modes.  We are totally committed to the use of NMR spectroscopy (in association with mass spectrometry) as a definitive bio-screening tool, and the latest technology developments now allow the deployment of the platform on an industrial scale.”

Professor Jeremy Nicholson, Director of the MRC-NIHR Phenome Centre and Head of the Department of Surgery and Cancer at Imperial College London

Weitere Informationen